Oseltamavir: Difference between revisions
| Line 9: | Line 9: | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
5 day course | ''5 day course'' | ||
*1-8 months: | *1-8 months: 3 mg/kg/day PO BID | ||
*9-23 months: | *9-23 months: 3.5 mg/kg/day PO BID | ||
*2-12 years: | *2-12 years: | ||
**<15kg: 30 mg PO BID | **<15kg: 30 mg PO BID | ||
Revision as of 19:39, 19 June 2015
General
- Type:
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Influenza
75mg PO BID x5d
Pediatric Dosing
5 day course
- 1-8 months: 3 mg/kg/day PO BID
- 9-23 months: 3.5 mg/kg/day PO BID
- 2-12 years:
- <15kg: 30 mg PO BID
- 16-23kg: 45 mg PO BID
- 24-40kg: 60 mg PO BID
- >40kg: 75 mg PO BID
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: